Home

 

Enabling Powerful POC and Mobile Diagnostics

There is a significant need for highly sensitive mobile diagnostics that can be performed closer to the patient at point of care, e.g., decentralized diagnostics. To meet this need, LamdaGen has developed a category-defining digital diagnostic platform that enables significant performance advantages over central laboratory testing relative to speed, high sensitivity, precise quantitation and importantly – mobility.

LamdaGen’s L’AuRa technology enables powerful adaptive mobile diagnostic systems that are simple, compact and cost effective. L’AuRa’s game-changing diagnostic platform provides our partners with robust testing systems that offer:

  • Competitive advantages
  • Deeper market penetration and new market entry
  • Accelerated growth

L’AuRa couples its proprietary digital detection with its nano-based biosensors to enable diagnostics systems with high sensitivity, precise quantitation and rapid performance in truly mobile or POC formats.

L'AuRa digital diagnostics are rapid, and highly sensitive with quantitative results

Chart above illustrates L’AuRa’s diagnostic performance in terms of time and sensitivity as compared to ELISA and Lateral Flow

L'AuRa disposable single-use test cartridge

Introducing L’AuRa:
Read More ›

Saliva-based Cortisol Assay:
Read More ›

Troponin I (cTnI) Ap Note:
Read More ›

LamdGen’s Micro-8 nano-based LSPR biosensors for multiplexed rapid and precise diagnostics

LamdGen’s Micro-8 nano-based biosensors for multiplexed targets

 

L’AuRa Digital Diagnostics

The L’AuRa diagnostic system is ideal for enabling high sensitivity, quantitative POC, mobile rapid testing.

Learn More ›

LightPath™ S4

LamdaGen’s LightPath S4 system performs highly sensitive label-free, real-time monitoring and characterization of biomolecular interactions.

Learn More ›

LSPR Biosensors

LamdaGen’s metallic thin-film LSPR-based Optical Biosensors for research and development in the areas of Life Science and Cleantech.

Learn More ›

News & Literature

LamdaGen Corporation Receives Notice of Allowance to Grant European Patent for Enzymatic Assays Performed on LSPR Based Plasmonic Nano-Sensors Read More ...

ACS Nano Publication: Cellular Functional Immunoanalysis Using LamdaGen LSPR Biosensors Read More ...

More News >